SCHEMBL5985876

SCHEMBL5985876

[CH2]CCCCC#CCCC(CCCC)CCCCCCCCCCC[CH2]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
PTPN7 P35236 4/20 0.36
HMGCR P04035 2/20 0.36
ALDH1A1 P00352 4/20 0.33
TDP1 Q9NUW8 3/20 0.33
RECQL P46063 2/20 0.33
CYP3A4 P08684 1/20 0.32
TSHR P16473 1/20 0.32
DNM1 Q05193 2/20 0.32
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
ALOX12 P18054 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
MCL1 Q07820 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5986294 1.00 LMNA (0.38) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5986682 0.96 LMNA (0.40) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5984666 0.96 LMNA (0.40) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5987020 0.96 LMNA (0.40) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5986129 0.94 LMNA (0.39) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5984450 0.94 LMNA (0.39) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5984293 0.94 LMNA (0.39) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5987095 0.92 LMNA (0.33) LMNAPTPN7HMGCRTDP1RECQL
SCHEMBL5987161 0.91 LMNA (0.36) LMNAPTPN7HMGCRALDH1A1TDP1
SCHEMBL5984785 0.89 LMNA (0.35) LMNAPTPN7HMGCRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7018993-B2 Antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-03-28 US disclosed
US-20030158164-A1 Novel antiandrogenic agent CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-21 US disclosed
EP-1304334-A1 NOVEL ANTIANDROGENIC AGENT CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-04-23 EP disclosed
EP-1219631-A1 ANTIANDROGEN AGENTS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2002-07-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158164-A1 Novel antiandrogenic agent NR5A1, CYP19A1, HSD17B11 LMNA 2182/4885PTPN7 4128/4885HMGCR 759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.